rutecarpine has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, M; Lv, J; Ni, H; Wang, C; Yang, H; Zhang, L | 1 |
1 other study(ies) available for rutecarpine and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Rutaecarpine attenuates high glucose-induced damage in AC16 cardiomyocytes by suppressing the MAPK pathway.
Topics: Apoptosis; Diabetic Cardiomyopathies; Glucose; Humans; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2023 |